Ovid Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	448	212	67	228	131	226
Market Cap Growth	2074.45%	214.52%	-70.36%	73.67%	-41.97%	48.73%
Enterprise Value	295.41	154.55	27.81	136.55	18.07	38.07
Last Close Price	2.40	1.63	0.93	3.22	1.86	3.21
PE Ratio	-	-	-	-	-	1.82
PS Ratio	62.89	29.26	119.20	580.68	87.22	1.08
PB Ratio	2.02	1.62	0.99	2.59	0.99	1.26
P/TBV Ratio	1.09	0.92	0.97	2.59	0.99	1.22
P/FCF Ratio	-	-	-	-	-	1.91
P/OCF Ratio	-	-	-	-	-	1.90
EV/Sales Ratio	41.48	21.31	49.14	348.34	12.02	0.18
EV/EBITDA Ratio	-	-	-	-	-	0.31
EV/EBIT Ratio	-	-	-	-	-	0.31
EV/FCF Ratio	-	-	-	-	-	0.32
Debt / Equity Ratio	0.06	0.09	0.20	0.17	0.12	0
Net Debt / Equity Ratio	-0.72	-0.43	-0.56	-1.02	-0.85	-1.04
Net Debt / EBITDA Ratio	3.00	1.33	0.63	1.53	2.04	-1.51
Net Debt / FCF Ratio	3.40	1.47	0.68	1.96	1.99	-1.59
Asset Turnover	0.04	0.06	0.00	0.00	0.01	1.54
Quick Ratio	9.88	8.40	5.04	9.22	18.45	12.69
Current Ratio	10.17	8.97	5.32	9.55	18.79	12.87
Return on Equity (ROE)	-14.69%	-17.51%	-33.88%	-47.57%	-34.72%	109.98%
Return on Assets (ROA)	-25.35%	-34.91%	-52.40%	-39.61%	-31.76%	90.86%
Return on Invested Capital (ROIC)	-65.87%	-73.45%	-169.00%	-197.29%	-390.02%	2525.32%
Return on Capital Employed (ROCE)	-27.08%	-37.84%	-57.78%	-42.22%	-33.87%	106.34%
Earnings Yield	-	-	-	-	-	54.83%
FCF Yield	-	-	-	-	-	52.43%
Buyback Yield / Dilution	-26.81%	-3.99%	-0.46%	-0.22%	-3.46%	-16.45%
Total Shareholder Return	-26.81%	-3.99%	-0.46%	-0.22%	-3.46%	-16.45%

SEC Filings: 10-K · 10-Q